Sarcoidosis Board decisions

The Board denied the Veteran's claim for an initial compensable rating for sarcoidosis and remanded the claim for service connection for a right elbow disorder.

The Board remands the claims for service connection for asthma, sarcoidosis, and pneumothorax to correct pre-decision duty-to-assist errors.

The Board remands the claim for service connection for sarcoidosis to obtain an addendum medical opinion addressing the holding in Spicer v. McDonough, as the RO did not attempt to obtain such an opinion before deciding the claim.

The Board remands the claim for service connection for sarcoidosis to obtain an addendum opinion addressing the etiology of the Veteran's currently diagnosed condition.

The veteran withdrew all pending appeals, and the Board dismissed the appeals.

The Board granted a total disability rating based on individual unemployability (TDIU) due to the Veteran's service-connected disabilities, but denied an increased rating for depressive disorder.

The Board granted service connection for sarcoidosis due to the Veteran's exposure to toxins at Camp Lejeune, but remanded the claim for scleroderma for further development.

The Veteran was granted an earlier effective date of August 1, 2023, for the grant of service connection for sarcoidosis with asthma. The initial rating for diabetes mellitus type 2 was denied prior to March 12, 2024, but a 20 percent rating was granted from that date.

The appeal for entitlement to service connection for sarcoidosis was dismissed due to a procedural defect of an improper concurrent election of multiple review options.

The Board granted service connection for the cause of the Veteran's death, finding that his anaplastic thyroid carcinoma was related to his in-service exposure to herbicide agents.

The Board remands the claim for service connection for sarcoidosis to obtain a medical opinion and additional evidence.

The Board remands the claim for an initial rating in excess of 10 percent for sarcoidosis to correct a pre-decisional duty to assist error.

The Board denied the veteran's claim for a certificate of eligibility for specially adapted housing and remanded the issue of an initial compensable disability rating for service-connected pulmonary sarcoidosis.

The appeal was dismissed as the Veteran did not timely file a Board Appeal request with respect to the rating decision issued on May 22, 2023.

The Veteran is granted a higher level of special monthly compensation (SMC) at the intermediate 'I and 12' rate under 38 U.S.C. § 1114(p), but the claim for service connection for sarcoidosis of the lungs is remanded.

The Veteran's service-connected sarcoidosis has been granted a 30 percent evaluation, and TDIU due to his service-connected disabilities has also been granted.

The Board denied service connection for bilateral hearing loss and denied increased ratings for allergic rhinitis, sarcoidosis, and residual scars status post basal cell carcinoma. Service connection was granted for chronic sinusitis.

The Board denied the Veteran's claims for service connection for sarcoidosis and obstructive sleep apnea, as there was no evidence linking these conditions to his military service.

The Board denied the Veteran's claim for service connection for sarcoidosis, finding no evidence of a medical nexus between the condition and his active service.

The Board denied the Veteran's claim for service connection for sarcoidosis, finding that the evidence did not support a causal relationship between the Veteran's current condition and his active service, including exposure to Agent Orange.